ArticleJAMA internal medicine2021

Potential Cost Implications for All US Food and Drug Administration Oncology Drug Approvals in 2018.

Patrick C DeMartino et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.